GU Cancers 2023 | UNITE: enfortumab vedotin in advanced urothelial cancer

Vadim Koshkin, MD, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, talks on the retrospective UNITE study investigating the efficacy of enfortumab vedotin in advanced urothelial cancer. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.